Pneumococcal Disease: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
MonthsYears
2345610111213141518232356121819506061646575≥ 76
Austria
PCV
PCV
PCV1
PCV
PCV+PPSV232
Belgium
PCV13
PCV13
PCV13
PCV13+PPSV233
PCV13+PPSV234
Bulgaria
PCV
PCV
PCV5
PCV13+PPSV236
Croatia
PCV7
PCV7
PCV7
Cyprus
PCV
PCV
PCV8
PPSV239
PPSV2310
Czech Republic
PCV11
PCV12
PCV13
PCV13+PPSV2314
PCV13+PPSV2315
Denmark
PCV13
PCV13
PCV13
PPSV2316
Estonia
PCV13+PPSV2317
Finland
PCV10
PCV10
PCV10
PCV13+PPSV2318
France
PCV
PCV
PCV
PCV13+PPSV2319
Germany
PCV
PCV
PCV
PCV20
PPSV2321
Greece
PCV13
PCV13
PCV13
PCV13
PCV13
PCV13+PPSV2322
PCV13+PPSV23
PCV13+PPSV23
Hungary
PCV13
PCV13
PCV13
PCV13+PPSV23
Iceland
PCV10
PCV10
PCV10
PPSV2323
Ireland
PCV
PCV
PCV
PPSV2324
Italy
PCV
PCV
PCV
PCV13+PPSV2325
Latvia
PCV
PCV
PCV
Liechtenstein
PCV13
PCV13
PCV13
Lithuania
PCV
PCV
PCV26
Luxembourg
PCV
PCV
PCV
PCV
PCV27
PCV28
Malta
PCV10
PCV10
PCV10
Netherlands
PCV29
PCV
PCV
PPSV2330
Norway
PCV13
PCV13
PCV13
PPSV2331
Poland
PCV
PCV
PCV
PCV
Portugal
PCV1332
PCV13
PCV13
Romania
PCV13
PCV13
PCV13
Slovakia
PCV
PCV
PCV
PCV33
Slovenia
PCV13
PCV13
PCV13
PCV13+PPSV2334
Spain
PCV35
PCV35
PCV35
PPSV23 / PCV+PPSV2336
PPSV2337
Sweden
PCV
PCV
PCV
PPSV2338

Footnotes:

  1. Minimum interval of 6 month after second dose
  2. PCV13 and PPV23 one year apart.
  3. for additional information please refer to the relevant recommendations for pneumococcal vaccination (dated 2020: https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9562_fiche_vaccination_antipneumococcique_vweb.pdf) and specifically for the vaccination of immunocompromised and chronically ill children and adults: https://www.health.belgium.be/en/advisory-report-9158-ic-patients-and-vaccination
  4. PCV13 and PPV23 one year apart. https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9562_fiche_vaccination_antipneumococcique_vweb.pdf
  5. Not earlier than 6 months after the previous dose
  6. PCV13 is given starting from 50 years. The scheme is completed with PPSV23 in 65 years and older
  7. Introduced in 2019
  8. catch-up possible until 6 years if previous recommended doses were missed
  9. vaccines only given on specific indications
  10. No revaccination recommended.
  11. PCV13. First dose. Recommendation only, the vaccination is covered by the health insurance
  12. Recommendation only, the vaccination is covered by the health insurance. 2nd dose.
  13. 3rd dose.
  14. Any PCV or PPSV23. Vaccination is especially recommended for people with chronic lung disease (includes moderate and severe bronchial asthma), with long-term medical treatment; persons with heart disease and/or large vessels with long-term systemic medical treatment, such as hypertension; people with chronic kidney and liver disease; patients with diabetes mellitus; patients with an immune disorder system (eg patients with immunosuppressive treatment (steroids, HIV infections, etc.) and asplenia / hyposplenia; patients with anticancer treatment; patients before / after solid organ and / or bone marrow transplantation; people with severe obesity (BMI over 40 kg / m2) and persons over 65 years of age.
  15. https://www.vakcinace.eu/data/files/downloads/ockovaci_kalendar_dospsdatem.pdf
  16. https://www.ssi.dk/vaccinationer/risikogrupper/personer-over-65-ar
  17. https://www.vaktsineeri.ee/en/node/168 Payment for vaccination Adults can be vaccinated against diphtheria and tetanus free of charge (protection must be renewed every 10 years).The state also covers the costs of vaccination in the event of an outbreak of measles (for the sick or exposed). Other vaccines are chargeable.
  18. https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/pneumococcal-vaccines
  19. For individuals from 5 years with increased risk of invasive pneumococcal disease. the scheme is based upon history of vaccination with PCV vaccines. if not previously vaccinated: PCV13 then PPSV23 (at least 8 weeks in between). If previous vaccination with PPSV23 >one year: PCV13 then PPSV23 (at least 5 years after initial PPSV23). If previously vaccinated with PCV13+PPSV23: further PPSV23 at least 5 years after the last dose.
  20. number of doses necessary varies according to age
  21. https://edoc.rki.de/bitstream/handle/176904/2961/23tLoXFfwIoxE.pdf?sequence=1&isAllowed=y
  22. PPSV is recommended in addition to PCV13 at least 2 months after the last dose of PCV13 in subjects > 2 years with an increased risk of disease from pneumococcal infections. A booster dose of PPSV23 is recommended 5 years after the first dose
  23. One dose is recommended for all adults over age 60. For risk groups one dose of conjugated vaccine and one dose of PPS vaccine is recommended after 2 years of age . for more information see: https://www.landlaeknir.is/servlet/file/store93/item23265/Lei%C3%B0beiningar%20um%20notkun_b%C3%B3luefna_gegn_pneum%C3%B3kokkum-final.pdf
  24. The vaccine is free of charge, but administration fees may be charged to patient (based on income and eligibility for free healthcare)
  25. one dose of PCV13 at 65 years and one dose PPSV after at least 8 weeks
  26. Can be administered concomitantly with MMR
  27. For individuals from 18 years of age, immunosupporessed or with specific conditons putting them at risk of severe pneumococcal infection the following recommendations apply: For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
  28. For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
  29. https://www.rivm.nl/en/pneumococci/information-for-policy-makers
  30. Implementation starting from fall 2020. Vaccination recommended for healthy adults aged 60 to 75 years. First dose at 60 years followed by booster doses every 5 years with a last dose at 75 years. More information available at: https://www.rivm.nl/pneumokokken/pneumokokkenvaccinatie-voor-ouderen https://www.rivm.nl/en/pneumococci/information-for-policy-makers
  31. One dose if not vaccinated in the previous 10 years. Reimbursed for some at-risk groups. https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/pneumokokkvaksinasjon---veileder-fo/
  32. https://www.dgs.pt/paginas-de-sistema/saude-de-a-a-z/programa-nacional-de-vacinacao/vacinas-do-pnv/infecoes-por-streptococcus-pneumoniae.aspx
  33. Recommended to all. Mandatory to persons residing in social care facilities
  34. PCV and PPSV23 recommended, self-paid
  35. For recommendations in children and adults with high risk conditions Please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/riesgo/home.htm
  36. For recommendations in children and adults with high risk conditions, refer to: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/riesgo/home.htm
  37. Additional information https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Vacunacion_poblacion_adulta.pdf
  38. All adults 65 years and older are recommended vaccination with PPV23. The funding and extent of the offer varies by region. In addition, and as of 1 Dec 2022, all individuals are eligible for a free vaccination against invasive pneumococcal disease during the year they turn 75, through the national vaccination program for risk groups. More information is available here: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/nationella-vaccinationsprogram/program-for-riskgrupper/ .